• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GELESIS SRL PLENITY; DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GELESIS SRL PLENITY; DELIVERY SYSTEM Back to Search Results
Model Number MC0420
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Dyspnea (1816)
Event Type  Injury  
Event Description
Chest tightness that evolved to shortness of breath [chest discomfort].Chest tightness that evolved to shortness of breath [dyspnoea].Case narrative: this initial spontaneous report was received from the united states of america reported by an health care professional on (b)(6) 2023.A 43-year-old patient of unknown gender experienced chest tightness and shortness of breath while on plenity for weight management.The patient¿s medical history included a cholecystectomy in 2018.Concurrent conditions included a sugar addiction with a bes (binge eating scale) score of 10, and patient disclosed having gerd (gastroesophageal reflux disease) which was controlled and often needed to clear the throat for no apparent reason associated with allergies.The patient had known allergies to latex, sulfa, penicillin, and kiwi active ingredients, which required allergy testing and care from an allergist.Concomitant medication included vitamin a.On (b)(6) 2023, the patient started therapy with plenity at a dose of 3 capsules, oral, twice daily for weight management.Lot number and expiry date of plenity were not provided.On an unknown date, approximately two weeks ago, the patient experienced chest tightness (pt: chest discomfort) that evolved to shortness of breath (pt: dyspnoea).The patient called 911 and was treated with an epipen by paramedics, and transferred to the er (emergency room) via ambulance.The patient was observed overnight.Additional treatment received in the ed was not provided.The patient recovered approximately 12 hours after the onset of symptoms.The patient was advised not to restart plenity due to the severity of symptoms.The patient was provided with plenity¿s ingredient list to review with an allergist.The reporter thought that the events were possibly related to plenity as the patient had a kiwi allergy and might have experienced a cross-allergic reaction with citric acid found in plenity.Action taken: patient discontinued plenity due to events of chest discomfort and dyspnea.Outcome of the events of chest discomfort and dyspnea was reported as resolved.This case is assessed as serious given the need for intervention and overnight observation in the er required for the events chest discomfort and dyspnea this case was verified by a healthcare professional.Company comment: this spontaneous report refers to a 43-year-old patient of unknown gender who experienced chest discomfort and dyspnea while on plenity for weight management.The patient¿s medical history included a cholecystectomy and concurrent conditions included sugar addiction, and gerd.The patient has known allergies to latex, sulfa, penicillin, and kiwi active ingredients, which require allergy testing and care from an allergist.The patient experienced chest discomfort and dyspnea, called 911 and was treated with an epipen by paramedics and transferred to the er.The patient was observed overnight and recovered approximately 12 hours after the onset of symptoms.This case is assessed as serious given the need for intervention and overnight observation in the er required for the events chest discomfort and dyspnea.Based on the reasonable temporal relationship, spontaneous nature of the report, and known history of allergies causality is assessed as possible for both events.More information regarding underlying etiology, and investigations is required for a more meaningful assessment of the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLENITY
Type of Device
DELIVERY SYSTEM
Manufacturer (Section D)
GELESIS SRL
via verdi, 188
calimera (le) 73021
IT  73021
Manufacturer (Section G)
GELESIS, INC.
501 boylston street, suite 610
2
boston MA 02116
Manufacturer Contact
via verdi, 188
calimera (le) 73021
MDR Report Key16512717
MDR Text Key310984575
Report Number3012121187-2023-00004
Device Sequence Number1
Product Code QFQ
Combination Product (y/n)N
PMA/PMN Number
DEN180060
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMC0420
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
VITAMIN A (RETINOL).
Patient Outcome(s) Required Intervention;
-
-